Melatonin Vitabalans 5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

melatonin vitabalans 5 mg tabletti

vitabalans oy - melatonin - tabletti - 5 mg - melatoniini

HYDROXYZINE ORION 25 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

hydroxyzine orion 25 mg tabletti, kalvopäällysteinen

orion corporation - hydroxyzini hydrochloridum - tabletti, kalvopäällysteinen - 25 mg - hydroksitsiini

Lidokain Aguettant 10 mg/ml injektioneste, liuos, esitäytetty ruisku Suomi - suomi - Fimea (Suomen lääkevirasto)

lidokain aguettant 10 mg/ml injektioneste, liuos, esitäytetty ruisku

laboratoire aguettant - lidocaine hydrochloride monohydrate - injektioneste, liuos, esitäytetty ruisku - 10 mg/ml - lidokaiini

Lidokain Aguettant 20 mg/ml injektioneste, liuos, esitäytetty ruisku Suomi - suomi - Fimea (Suomen lääkevirasto)

lidokain aguettant 20 mg/ml injektioneste, liuos, esitäytetty ruisku

laboratoire aguettant - lidocaine hydrochloride monohydrate - injektioneste, liuos, esitäytetty ruisku - 20 mg/ml - lidokaiini

Octreotide ratiopharm 10 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten Suomi - suomi - Fimea (Suomen lääkevirasto)

octreotide ratiopharm 10 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten

teva b.v. - octretide acetate - injektiokuiva-aine ja liuotin, depotsuspensiota varten - 10 mg - oktreotidi

Octreotide ratiopharm 20 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten Suomi - suomi - Fimea (Suomen lääkevirasto)

octreotide ratiopharm 20 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten

teva b.v. - octretide acetate - injektiokuiva-aine ja liuotin, depotsuspensiota varten - 20 mg - oktreotidi

Octreotide ratiopharm 30 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten Suomi - suomi - Fimea (Suomen lääkevirasto)

octreotide ratiopharm 30 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten

teva b.v. - octretide acetate - injektiokuiva-aine ja liuotin, depotsuspensiota varten - 30 mg - oktreotidi

Lumeblue (previously known as Methylthioninium chloride Cosmo) Euroopan unioni - suomi - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metyylitioniniumkloridia - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Melatonin Unimedic Pharma 1 mg/ml oraaliliuos Suomi - suomi - Fimea (Suomen lääkevirasto)

melatonin unimedic pharma 1 mg/ml oraaliliuos

unimedic pharma ab - melatonin - oraaliliuos - 1 mg/ml - melatoniini

Jayempi Euroopan unioni - suomi - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - graft hylkääminen - immunosuppressantit - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.